How to have joy at work
Jessica Perlo is the Director for Joy at Work at the Institute for Healthcare Improverment, and James Mountford is direct or of quality at the Royal Free London NHS Foundation Trust.
Together they joined us at the International Forum on Quality and Safety in Healthcare to discuss joy at work - what that concept actually means, and practically,... (Source: The BMJ Podcast)
Source: The BMJ Podcast - April 5, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
How to have joy at work
Jessica Perlo is the Director for Joy at Work at the Institute for Healthcare Improverment, and James Mountford is direct or of quality at the Royal Free London NHS Foundation Trust.
Together they joined us at the International Forum on Quality and Safety in Healthcare to discuss joy at work - what that concept actually means, and practically, how hospitals can start implementing it.
Watch Jessica’s session at the forum
https://internationalforum.bmj.com/glasgow/2018/09/20/a1-leadership-models-for-co-producing-a-joyful-workforce/
BMJ's wellbeing campaign
https://www.bmj.com/wellbeing
https://www.facebook.com/groups/5...
Source: The BMJ Podcast - April 5, 2019 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Part 2 - A phase II study of Anti-PD1 (nivolumab) therapy as pre- and post-operative therapy in metastatic renal cell cancer (ADAPTeR)
Samra Turajlic The Royal Marsden NHS Foundation Trust, London, UK discusses the second part of A phase II study of Anti-PD1 (nivolumab) therapy as pre- and post-operative therapy in metastatic renal c...
Author: kidneycancer
Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts
Martin Gore 1951 - 2019
James Larkin of the The Royal Marsden NHS Foundation Trust pays tribute to his friend and legendary oncologist Martin Gore at the Kidney Cancer International Symposium 2019 in Dubrovnik, Croatia
Author: kidneycancer
Added: 03/30/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2019 Category: Cancer & Oncology Source Type: podcasts
Cell-free tumour DNA (cfDNA) detection in advanced renal cell carcinoma
Samra Turajlic, MD The Royal Marsden NHS Foundation Trust outlines Cell-free tumour DNA (cfDNA) detection in advanced renal cell carcinoma at the Kidney Cancer Association International Symposium 2019...
Author: kidneycancer
Added: 03/30/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2019 Category: Cancer & Oncology Source Type: podcasts
No nephrectomy versus deferred nephrectomy
Axel Bex Royal Free London NHS Foundation Trust, UCL Division of Surgical and Interventional Science, London, UK and The Netherlands Cancer Institute, Amsterdam, Netherlands discusses "No nephrectomy ...
Author: kidneycancer
Added: 03/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 29, 2019 Category: Cancer & Oncology Source Type: podcasts
Safeguarding LGBT+ young people
Recent years have seen political and social progress for people who identify as LGBT+ (lesbian, gay, bisexual, and transgender; the “+” indicating inclusion of other minority sexual and gender identities).
Yet international evidence shows ongoing health and social inequalities in this group, many of which emerge during adolescence and represent unique safeguarding risks.
In this podcast, Kate Addlington, psychiatry traine e and associate editor at The BMJ is joined by Ginger Drage, expert patient educator at University College London, Jessica Salkind, academic clinical fellow in paediatrics& teaching lead for LGBT+,...
Source: The BMJ Podcast - February 15, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Safeguarding LGBT+ young people
Recent years have seen political and social progress for people who identify as LGBT+ (lesbian, gay, bisexual, and transgender; the “+” indicating inclusion of other minority sexual and gender identities).
Yet international evidence shows ongoing health and social inequalities in this group, many of which emerge during adolescence and represent unique safeguarding risks.
In this podcast, Kate Addlington, psychiatry trainee and associate editor at The BMJ is joined by Ginger Drage, expert patient educator at University College London, Jessica Salkind, academic clinical fellow in paediatrics & teaching lead for LG...
Source: The BMJ Podcast - February 15, 2019 Category: General Medicine Authors: BMJ Group Source Type: podcasts
What To Achieve With The TRACERx Renal Study
Samra Turajlic, M.D. Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, Discusses What To Achieve With The TRACERx Renal Study. At the Seventeenth International Kidney Cancer Sym...
Author: kidneycancer
Added: 01/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2019 Category: Cancer & Oncology Source Type: podcasts
Results From TRACERx Renal Study
Samra Turajlic, M.D. Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, Discusses Results From TRACERx Renal Study. At the Seventeenth International Kidney Cancer Symposium on No...
Author: kidneycancer
Added: 01/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2019 Category: Cancer & Oncology Source Type: podcasts
Discussing The TRACERx Renal Study
Samra Turajlic, M.D. Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, Discusses The TRACERx Renal Study. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018...
Author: kidneycancer
Added: 01/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2019 Category: Cancer & Oncology Source Type: podcasts
HbA1c - when it might not be accurately measuring glycemic control
HbA1c concentration is used as the biomarker for long term glycaemic control, however if the lifespan of red blood cells is altered, that may lead to an over, or under estimation of that control.
In this podcast Ravinder Sodi, consultant clinical biochemist at University Hospitals of Morecambe Bay NHS Foundation Trust, explains when to suspect... (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 15, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
HbA1c - when it might not be accurately measuring glycemic control
HbA1c concentration is used as the biomarker for long term glycaemic control, however if the lifespan of red blood cells is altered, that may lead to an over, or under estimation of that control.
In this podcast Ravinder Sodi, consultant clinical biochemist at University Hospitals of Morecambe Bay NHS Foundation Trust, explains when to suspect HbA1c is not an accurate measure of glycemic control, and what alternative tests are available.
Read the full article:
https://www.bmj.com/content/363/bmj.k4723 (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 15, 2019 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Tracking Renal Cancer Evolution Through Space And Time: Implications For Patient Management
Samra Turajlic BA, MBBS, MRCP, PhD, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust, London Cancer Research UK Clinician Scientist, Francis Crick Institute, London discusses Trackin...
Author: kidneycancer
Added: 11/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 8, 2018 Category: Cancer & Oncology Source Type: podcasts
